Pharma Pulse 3/7/24: Rite Aid Enters into APA, S.E.C. Investigates OpenAI & more

How the Pandemic Changed the Way Pharma Looks at Data Integrity in 2024

In this Pharmaceutical Executive video interview, Daniel Ayala, Chief Security and Trust Officer, Dotmatics, discusses data security threats from human error to AI tech and how COVID-19 impacted data integrity.

U.S. Measles Case Count Up to 41 in 2024

The report from Feb. 29 states that cases have been reported in Arizona, California, Florida, Georgia, Indiana, Louisiana, Maryland, Michigan, Minnesota, Missouri, New Jersey, New York City, Ohio, Pennsylvania, Virginia and Washington.

S.E.C. Is Investigating OpenAI Over Its Board’s Actions

The U.S. regulator opened its inquiry after the board unexpectedly fired the company’s chief executive, Sam Altman, in November.

Rite Aid Enters into Agreement to Divest Majority of Health Dialog Assets

Rite Aid Corporation announced that it has entered into an asset purchase agreement for the partial sale of its Health Dialog business to Carenet Health, a provider of healthcare engagement, clinical support, telehealth and advocacy solutions.

@GS1_US on Twitter/X:

What tools and resources are available to help you enable #supplychain visibility? Get the inside scoop with our on-demand #Traceability Certificate Course. https://ow.ly/OvUv50QwSK7

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs